Avak Kahvejian is a distinguished professional in the biotechnology sector, currently serving as the Founding CEO of Abiologics since March 2021. Additionally, Avak holds the position of General Partner at Flagship Pioneering since July 2011. Avak's leadership extends to various organizations, including roles as founding CEO and board member at multiple companies such as Ampersand Biomedicines, ProFound Therapeutics, Sail Biomedicines, Cellarity, and Ring Therapeutics. Avak has also been involved with Generate Biomedicines, Inc. as Founding Co-CEO and with Cygnal Therapeutics as Chief Innovation Officer and founding president. Avak's academic credentials include a Ph.D. and B.Sc. in Biochemistry from McGill University.
Org chart
This person is not in the org chart
